SEC Form 4 · accession 0001103780-15-000027
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Bunka
Officer — CEO · Director · 10% Owner
Period of report
Jan 20, 2010
Accepted (ET)
Jun 24, 2015 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 24, 2015 | P | 10,000 | $0.19 | A | 4,156,580 | D | |
| Common Shares | Jun 24, 2015 | P | 5,000 | $0.156 | A | 4,161,580 | D | |
| Common Shares | Jun 24, 2015 | P | 10,000 | $0.156 | A | 4,171,580 | D | |
| Common Shares | Jun 24, 2015 | P | 20,000 | $0.157 | A | 4,191,580 | D | |
| Common Shares | Jun 24, 2015 | P | 20,000 | $0.155 | A | 4,211,580 | D | |
| Common Shares | Jun 24, 2015 | P | 10,000 | $0.155 | A | 4,221,580 | D | |
| Common Shares | Jun 24, 2015 | P | 20,000 | $0.157 | A | 4,241,580 | D | |
| Common Shares | Jun 24, 2015 | P | 5,000 | $0.158 | A | 4,246,580 | D | |
| Common Shares | Jun 24, 2015 | P | 35,600 | $0.15 | A | 4,282,180 | D | |
| Common Shares | Jun 24, 2015 | P | 5,100 | $0.149 | A | 4,287,280 | D | |
| Common Shares | Jun 24, 2015 | P | 10,000 | $0.158 | A | 4,297,280 | D | |
| Common Shares | Jun 24, 2015 | P | 10,000 | $0.158 | A | 4,307,280 | D | |
| Common Shares | Jun 24, 2015 | P | 20,000 | $0.158 | A | 4,327,280 | D | |
| Common Shares | Jun 24, 2015 | P | 17,000 | $0.155 | A | 4,344,280 | D | |
| Common Shares | holding | — | — | — | 4,488,958 | I | Private Holding Company | |
| Common Shares | holding | — | — | — | 4,146,580 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.11 | holding | — | — | — | Dec 23, 2014 | Dec 23, 2019 | Common Shares | 500,000 | 500,000 | D |
| Stock Options | $0.35 | holding | — | — | — | Jul 11, 2011 | Jul 11, 2016 | Common Shares | 200,000 | 700,000 | D |
| Stock Options | $0.10 | holding | — | — | — | Jun 18, 2013 | Jun 18, 2018 | Common Shares | 225,000 | 925,000 | D |
| Warrants | $0.25 | holding | — | — | — | Mar 21, 2014 | Sep 21, 2015 | Common Shares | 100,067 | 1,025,067 | D |
| Warrants | $0.25 | holding | — | — | — | May 15, 2015 | May 15, 2017 | Common Shares | 170,000 | 170,000 | I |
Explanation of responses
- F1Purchase price was in Canadian Funds